Kura Oncology Inc stock is traded at $7.61, with a volume of 7,932,481. It is down -22.98% in the last 24 hours and down -28.54% over the past month. Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Previous Close:
$9.88
Open:
$10.21
24h Volume:
7,932,481
Relative Volume:
3.57
Market Cap:
$676.99M
Revenue:
$71.64M
Net Income/Loss:
-$294.57M
P/E Ratio:
-
EPS:
-$3.35
Net Cash Flow:
-$84.46M
1W Performance:
-29.01%
1M Performance:
-28.54%
6M Performance:
-17.73%
1Y Performance:
-23.59%
1-Day Range:
$7.47$10.21
1-Week Range:
$7.47$10.96
52-Week Range:
$7.36$13.90
Kura Oncology Inc Stock (KURA) Company Profile
Name
Kura Oncology IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 500-8800Address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS